Detalhe da pesquisa
1.
[A Case of Squamous Cell Carcinoma of the Breast].
Gan To Kagaku Ryoho
; 43(6): 749-52, 2016 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-27306813
2.
[A patient with primary breast cancer who responded remarkably well to neoadjuvant chemotherapy with FEC100 followed by Abraxane].
Gan To Kagaku Ryoho
; 40(5): 627-9, 2013 May.
Artigo
em Japonês
| MEDLINE | ID: mdl-23863587
3.
De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer.
Cancer Chemother Pharmacol
; 83(6): 1099-1104, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963212
4.
A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes.
Cancer Chemother Pharmacol
; 81(5): 923-933, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29594360
5.
Outpatient management without initial assessment for febrile patients undergoing adjuvant chemotherapy for breast cancer.
Mol Clin Oncol
; 5(4): 385-390, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27699031
6.
A Phase II Study of Adjuvant Chemotherapy of Tegafur-Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant Chemotherapy.
Anticancer Res
; 36(12): 6505-6509, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27919974